Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
KLX Energy Services
KLXE
$43.7M
| $196K | ﹤0.01% |
17,403
+15,166
| +678% | +$154K |
|
4302
Contango Silver & Gold Inc
CTGO
$651M
| $196K | ﹤0.01% |
+10,813
| New | +$207K |
|
4303
Compass Therapeutics
CMPX
$375M
| $196K | ﹤0.01% |
125,486
+95,183
| +314% | +$165K |
|
4304
PUT
General Mills
GIS
$19.2B
| $195K | ﹤0.01% |
+3,000
| New | +$194K |
|
4305
Biote Corp
BTMD
$50.4M
| $195K | ﹤0.01% |
39,505
+15,015
| +61% | +$77.4K |
|
4306
Lifeway Foods
LWAY
$479M
| $195K | ﹤0.01% |
+14,511
| New | +$183K |
|
4307
Comp X International
CIX
$371M
| $194K | ﹤0.01% |
7,692
+1,811
| +31% | +$37.5K |
|
4308
Lexicon Pharmaceuticals
LXRX
$1.07B
| $194K | ﹤0.01% |
127,016
+87,827
| +224% | +$104K |
|
|
PDS
4309
Precision Drilling
PDS
$977M
| $194K | ﹤0.01% |
3,572
+1
| +0% | +$58 |
|
4310
Sumitomo Mitsui Financial
SMFG
$165B
| $194K | ﹤0.01% |
20,000
| – | – |
|
|
OPTN
4311
DELISTED
OptiNose
OPTN
| $193K | ﹤0.01% |
9,985
+5,822
| +140% | +$106K |
|
|
MACK
4312
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $193K | ﹤0.01% |
14,380
+12,535
| +679% | +$158K |
|
4313
Actinium Pharmaceuticals
ATNM
$24.8M
| $192K | ﹤0.01% |
37,716
+33,064
| +711% | +$170K |
|
4314
PDS Biotechnology
PDSB
$41.4M
| $191K | ﹤0.01% |
38,402
+33,488
| +681% | +$166K |
|
4315
Cato Corp
CATO
$65.1M
| $191K | ﹤0.01% |
26,691
+20,890
| +360% | +$148K |
|
|
LOGC
4316
DELISTED
ContextLogic
LOGC
| $189K | ﹤0.01% |
31,838
+26,804
| +532% | +$131K |
|
4317
Hippo Holdings
HIPO
$879M
| $189K | ﹤0.01% |
20,761
+14,938
| +257% | +$124K |
|
4318
Seres Therapeutics
MCRB
$50.4M
| $189K | ﹤0.01% |
6,759
-16,301
| -71% | -$428K |
|
4319
CALL
Arbutus Biopharma
ABUS
$913M
| $188K | ﹤0.01% |
+75,000
| New | +$147K |
|
|
4320
PUT
Arbutus Biopharma
ABUS
$913M
| $188K | ﹤0.01% |
+75,000
| New | +$147K |
|
|
XOMA
4321
DELISTED
Xoma
XOMA
| $187K | ﹤0.01% |
10,088
+8,722
| +639% | +$144K |
|
4322
PUT
Hershey
HSY
$36.6B
| $186K | ﹤0.01% |
1,000
-199,000
| -100% | -$37.7M |
|
4323
Bassett Furniture
BSET
$175M
| $186K | ﹤0.01% |
11,195
+1,693
| +18% | +$26.9K |
|
4324
Karooooo
KARO
$1.97B
| $186K | ﹤0.01% |
7,641
+5,022
| +192% | +$121K |
|
|
MAG
4325
DELISTED
MAG Silver
MAG
| $185K | ﹤0.01% |
17,804
-152
| -0.8% | -$1.62K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.